Dr. Eyal S. Ron Joins Amacathera Board Of Directors To Drive Strategic Growth And Accelerate Innovation In Long-Acting Therapies
Joining AmacaThera's Board at this pivotal moment is a great honour, said Dr. Ron. Having collaborated closely with the ...
AmacaThera Inc.: Dr. Eyal S. Ron Joins AmacaThera Board of Directors to Drive Strategic Growth and Accelerate Innovation in Long-Acting Therapies
AmacaThera, a leading clinical-stage biotechnology company revolutionizing long-acting therapies, announces the appointment ...
New paper batteries biodegrade in six weeks, offers safer energy storage
Flint's paper batteries biodegrade within six weeks, offering a sustainable alternative to traditional energy storage.
Innovotech Inc. Reports Issue of European Patent for Antimicrobial Silver Periodate Compounds Coated onto Polymers for Medical Devices
TSXV:IOT) Innovotech Inc. Reports Issue of European Patent for Antimicrobial Silver Periodate Compounds Coated onto Polymers for Medical Devices ...
Battling an infodemic: the curious case of HMPV
Panic over HMPV, U.S. Surgeon General's cancer warnings on alcohol, IIT research, and more health updates summarized.
ConsumerQueen on MSN17h
Ulta Deals | Love Your Skin Event!
Looking for Ulta Deals and coupons? You've come to the right place, we'll update this post each week with the latest offers ...
Le Lézard21h
InnoGI Technologies and Bac3Gel Forge Partnership to Revolutionize Gut Microbiome Research
InnoGI Technologies and Bac3Gel are proud to announce a groundbreaking partnership that grants InnoGI Technologies exclusive distribution rights for Gut3Beads in the field of in vitro colonic models.
PharmiWeb21h
Zomedica Announces License & Supply Agreement with Cresilon Inc. to Market and Sell Vetigel(R) Hemostatic Gel in the Animal Health Market
License Agreement Expands Zomedica's Portfolio with Revolutionary Hemostatic Technology ANN ARBOR, MI / ACCESSWIRE / January 7, 2025 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), ...
Zomedica Corp.: Zomedica Announces License & Supply Agreement with Cresilon Inc. to Market and Sell Vetigel Hemostatic Gel in the Animal Health Market
License Agreement Expands Zomedica's Portfolio with Revolutionary Hemostatic Technology ANN ARBOR, MI / ACCESSWIRE / January 7, 2025 / Zomedica Corp. (NYSE American:ZOM) ("Zomedica" or the "Company"), ...